Gray KueberuwaChief Executive Officer at ImmunoKey LtdSpeaker
Profile
Dr Gray Kueberuwa is CEO and Co-Founder of ImmunoKey, a UK biotechnology company developing next-generation CAR-T cell therapies for solid tumours. He has experience across the cell-therapy development pathway, spanning discovery research, intellectual property, process development, GMP manufacturing, regulatory engagement and clinical operations. Prior to founding ImmunoKey, Gray held leadership roles within a cell-therapy company that progressed through acquisition, international expansion and public-market financing. At ImmunoKey, he leads corporate strategy, financing and development of the company’s multi-antigen, dual-receptor CAR-T platform, with the lead programme focused on relapsed ovarian cancer.
Agenda Sessions
ImmunoKey Ltd -Engineering Tumour Selectivity into Multi-Antigen CAR T-Cell Therapy. CARKey; A Dual-Receptor Platform for Solid Tumours
, 15:00View Session